Back
Madrigal Pharmaceuticals Stock Predictions
Sponsored
MDGL
Sponsored
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Buy
57
MDGL
Madrigal Pharmaceuticals
Last Price:
320.90
Seasonality Move:
35.27%
7 Day Trial
ALL ACCESS PASS
$
7
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.Madrigal Pharmaceuticals Stock Forecast
- Over the next 52 weeks, Madrigal Pharmaceuticals has on average historically risen by 26.2% based on the past 17 years of stock performance.
- Madrigal Pharmaceuticals has risen higher in 7 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 41.18%
-
Is Madrigal Pharmaceuticals Stock Undervalued?
The current Madrigal Pharmaceuticals [MDGL] share price is $317.09. The Score for MDGL is 57, which is 14% above its historic median score of 50, and infers lower risk than normal. - MDGL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Madrigal Pharmaceuticals Stock Go Up Next Year?
- Over the next 52 weeks, Madrigal Pharmaceuticals has on average historically risen by 26.2% based on the past 17 years of stock performance.
Madrigal Pharmaceuticals Stock Rating
Buy
57
Madrigal Pharmaceuticals (MDGL)
is a Buy
Is Madrigal Pharmaceuticals overpriced?
- Madrigal Pharmaceuticals has risen higher in 7 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 41.18%
Madrigal Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
madrigalpharma.com
52-Week Data
52-Week High:
368.29
52-Week Low:
168.25
Prediction Charts
Market Cap:
6.92B
Price in USD:
317.09
Volume:
277.16K
Beta:
1.03
Technical Analysis
SMA50:
248.85
SMA100:
256.27
SMA200:
247.65
52-Wk Change:
66.85%
Stock Predictions
-
Is Madrigal Pharmaceuticals stock public?
Yes, Madrigal Pharmaceuticals is a publicly traded company. -
What is the Madrigal Pharmaceuticals stock quote today?
The Madrigal Pharmaceuticals stock price is 317.09 USD today. -
How to buy Madrigal Pharmaceuticals stock online?
You can buy Madrigal Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Nov-1 | 274.98 | 319.58 | 321.19 | 262.85 |
Nov-4 | 320.00 | 331.32 | 337.44 | 310.02 |
Nov-5 | 331.00 | 337.61 | 337.63 | 316.67 |
Nov-6 | 341.59 | 338.31 | 345.04 | 327.69 |
Nov-7 | 339.38 | 354.85 | 368.29 | 337.50 |
Nov-8 | 356.71 | 350.70 | 357.05 | 343.00 |
Nov-11 | 357.42 | 339.66 | 357.81 | 338.03 |
Nov-12 | 335.57 | 339.25 | 341.19 | 327.41 |
Nov-13 | 342.58 | 315.15 | 342.58 | 314.02 |
Nov-14 | 310.94 | 302.67 | 315.56 | 302.54 |
Nov-15 | 303.29 | 288.58 | 303.29 | 272.72 |
Nov-18 | 290.25 | 303.49 | 308.43 | 288.80 |
Nov-19 | 305.00 | 314.17 | 320.89 | 304.35 |
Nov-20 | 315.75 | 317.09 | 323.99 | 310.84 |
Madrigal Pharmaceuticals Earnings
Madrigal Pharmaceuticals Earnings Report: Per Share Madrigal Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Madrigal Pharmaceuticals Forecast Revenue Growth
Madrigal Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Madrigal Pharmaceuticals and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $4.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.10 per share, and an increase next year of $10.03 per share.
* Madrigal Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.